Home > Boards > Free Zone > All Trading - Technical > What the UTZ!? (CCH)

I'm still in this to win this. I

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Carlgetsmoked Member Profile
Followed By 0
Posts 110
Boards Moderated 0
Alias Born 01/21/20
160x600 placeholder
Top Stories of the Day
TOP STORIES Premier Foods Shares Seen as Undervalued -- Market Talk
Top Company News of the Day
Corn Futures Falls as Rainfall is Expected -- Daily Grain Highlights
Front Month Nymex Natural Gas Rose 10.51% This Week to Settle at $4.0600 -- Data Talk
Front Month Nymex RBOB Gasoline Rose 1.67% This Week to Settle at $2.2913 -- Data Talk
Grimmway Farms Recalls Certain Carrots Due to Risk of Salmonella
Kimberly-Clark Reports 2Q Results, Offers Guidance -- Commodity Comment
GDP Growth Expected to Accelerate in 2Q -- Data Week Ahead
Veoneer Shares Touch 52-week High, Magna Plans to Acquire Co.
AbbVie Gets FDA OK for Pediatric Skin Infection Drug
FTSE 100 Index Ends the Week 0.28% Higher at 7027.58 -- Data Talk
STOXX Europe 50 Index Ends the Week 0.84% Higher at 3558.08 -- Data Talk
CAC 40 Index Ends the Week 1.68% Higher at 6568.82 -- Data Talk
DAX Ends the Week 0.83% Higher at 15669.29 -- Data Talk
STOXX Europe 600 Index Ends the Week 1.49% Higher at 461.51 -- Data Talk
EURO STOXX 50 Index Ends the Week 1.82% Higher at 4109.10 -- Data Talk
FTSE 100 Closed Higher Despite Volatile Week
Vonovia Unlikely to Secure Enough Support From Deutsche Wohnen Shareholders to Pursue Takeover
Kimberly-Clark Keeps Forecast of Favorable FX in 2021 -- Currency Comment
U.S. Economic Growth Moderated in July -- IHS Markit
Veoneer Shares Climb on Magna Acquisition Deal
FTSE Rises, Covid-19 Strategy and Brexit Tensions Could Hit Pound
AstraZeneca's Bydureon BCise Gets U.S. Approval For Type 2 Diabetes in Pediatric Patients
Carlgetsmoked   Saturday, 06/20/20 09:59:45 AM
Re: None
Post # of 25 
I'm still in this to win this. I was really looking through the S-4 yesterday and bottom line this is a "safe" place to park your cash. It's not going to make you rich beyond your wildest dreams but if you want a good steady growth dividend stock with a well managed century old company with a product that never gets old then this is the one for you. I'm predicting $15-$20 after merger. I really can't see it higher than $20 by year's end and maybe not even by then but in the face of so many companies revenues taking a hit in q's 1-3 I believe this company will show much better numbers compared to other sectors come end of year/q-4 and the consumer products sector will be one of the safer havens for parking your cash. Just my opinion and my hope of nice steady growth.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences